Source: Annual Congress 2008 - Pathophysiology of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Núñez, J. Sauleda, M. R. Julià, J. García-Aymerich, J. M. Antó, J. Gea, E. Monsó, F. Gómez, J. Roca, E. Farrero, A. Agustí, PAC-COPD Study Group (Palma de Mallorca, Illes Balears, Bunyola, Illes. Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2008; 32: Suppl. 52, 506

Member's Comments

No comment yet.

Related content which might interest you: Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Antielastin antibodies in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002 Angiopoietins in sputum supernatant of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Circulating tumor cells in chronic obstructive pulmonary disease patients Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003